Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

Liver checks are being offered at supermarkets and football matches and in offices as part of efforts to catch cancer early.

Thousands of people across England have been referred for liver cancer checks following the expansion of mobile scanning ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

Terry's nails, characterized by a white, frosted appearance with a narrow pink band, can indicate underlying health issues ...

Terry's nails, a nail abnormality characterized by a white, frosted appearance with a reddish-brown band at the tip, can ...

A shorter course of prophylactic antibiotics, or even no course at all, appeared to be noninferior to longer courses in ...

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...

In hospitalized patients with acute kidney injury and liver cirrhosis, baseline and peak levels of serum cystatin C can ...

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...